Company Analysis

SAB Biotherapeutics, Inc. (SABS)

Nasdaq: SABS · Biological Products, (No Diagnostic Substances) · Miami Beach, FL · filing with the SEC since 2020
Grade3.9
◀ Past 2.1● Present 4.6▶ Future 4.5
4 est.

Who runs SAB Biotherapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Reich Samuel J
CEO. First filing Jan 2021, latest Feb 5, 2026, 3 filings in all.
Officers reporting now
5
of 19 people with a filing in the last fifteen months
Directors reporting now
14
38 people on the record since 2021
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Kropotova AlexandraCHIEF MEDICAL OFFICERJun 2022Sep 18, 2026none
Reich Samuel JCEOJan 2021Feb 5, 2026none
Sullivan Eddie JoePRESIDENTOct 2021Feb 5, 2026none
To LucyChief Financial OfficerJul 2024Feb 5, 2026none
Bausch Christoph LawrenceCHIEF OPERATING OFFICEROct 2021Feb 5, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Jain RitadirectorJan 2026Jan 7, 2026none
Zaccardelli DaviddirectorJan 2026Jan 7, 2026none
Ellias Helen K.directorNov 2023Dec 18, 2025none
Giberson ScottdirectorJul 2022Dec 18, 2025none
Link DaviddirectorDec 2025Dec 18, 2025none
Lucera ErickdirectorApr 2023Dec 18, 2025none
Polvino William JamesdirectorOct 2021Dec 18, 2025none
Skyler Jay SdirectorMay 2024Dec 18, 2025none
Moin AndrewdirectorOct 2023Oct 1, 2025none
Petry JohndirectorOct 2023Oct 1, 2025none
Sessa Capital (Master), L.P.directorOct 2023Oct 1, 2025none
Sessa Capital Gp, LLCdirectorOct 2023Oct 1, 2025none
Sessa Capital Im Gp, LLCdirectorOct 2023Oct 1, 2025none
Sessa Capital Im, L.P.directorOct 2023Oct 1, 2025none
Earlier names on the record20, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SABS · research, not advice